title: Flows and flaws in primary central nervous system lymphoma.
authors.forename: Andrés J M
authors.initials: AJ
authors.lastname: Ferreri
authors.forename: Gerald
authors.initials: G
authors.lastname: Illerhaus
authors.forename: Emanuele
authors.initials: E
authors.lastname: Zucca
authors.forename: Franco
authors.initials: F
authors.lastname: Cavalli
mesh_terms: D000465:Algorithms; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D003561:Cytarabine / Q000627:therapeutic use; D003657:Decision Making; D004359:Drug Therapy, Combination; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D008727:Methotrexate / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003561:Cytarabine; D008727:Methotrexate